An observational study in Hospital-Acquired Infection and Influenza, sponsored by Hospices Civils de Lyon. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-01-30.
Sponsored by Hospices Civils de Lyon · Observational
Among 47 studies in Cross Infection with a site in France — 9 open to participants now, 9 under way, 1 of them phase 3. Cross Infection · France.
Among the 47 studies in Cross Infection with a site in France, this one is the 12th largest by planned enrollment of the 24 observational ones that give a count, is one of 3 that started in 2018, is one of 24 observational ones, and was the 23rd registered.
285 studies on the registry are indexed under Cross Infection; 48 are open to participants now.
Browse Cross Infection studies →9 of the 47 studies in Cross Infection with a site in France are open now. Recruiting first, the newest first:
Centre Hospitalier Régional Metz-Thionville · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
University Hospital, Lille · Sites in France
Ages 18+
University Hospital, Toulouse · Sites in France
Ages 18+
Hospices Civils de Lyon · Sites in France
Ages 18+ · Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 27 Cross Infection studies recruiting now, 22 (81%) set no upper age limit and 3 (11%) stop at 75 or younger; 5 take children under 18; 6 take healthy volunteers.
This study: 18 Years and older · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
47 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 3 started in 2018.
This study's planned enrollment of 500 is above the median of 351 across 115 observational studies indexed under Cross Infection.
Median enrollment 244 across the 23 interventional studies, 496 across the 24 observational. Of the 31 that completed or were terminated, 2 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 47 have an industry lead sponsor. The 10 most frequent:
Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.
Hospices Civils de Lyon has 4 studies filed under Cross Infection — fewer than ten, so there is no comparison to draw.
4 of the studies in Cross Infection with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05719259European Clinical Research Alliance for Infectious Diseases (ECRAID)Perpetual Observational Study - Ventilator Associated Pneumonia | 2026-12-01 |
| NCT06482463University Hospital, ToulouseDiagnostic of D-lactate in Cerebrospinal Fluid Level in Patients With Suspected Ventriculostomy-related Meningitis | 2027-02 |
| NCT06643039Hospices Civils de LyonNosocomial Respiratory Virus Infection | 2027-07-05 |
| NCT07822971Centre Hospitalier Régional Metz-ThionvilleImpact of an On-site Simulation-based Training Programme on Adherence to Standard Precautions and Healthcare-associated Infections in Adult Intensive Care | 2027-08-31 |
Among the 47 studies in Cross Infection with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Hospital-acquired influenza is associated with significant morbidity and mortality in hospitalized patients notably elderly patients. Furthermore, it is also associated with a large economic impact for the hospitals.
The transmission of influenza has been mostly reported in pediatric and long-stay units. The chains of transmission of influenza in acute-stay units have to be describe in order to prevent and control potential outbreaks. Furthermore, to know clinical symptoms seems to be important in order to identify potential sources of virus as soon as possible and to set up appropriate hygiene prevention measures. Moreover, the definition of the hospital-acquired influenza has to be harmonized for all over the studies, especially concerning the delay between the admission in the hospital and the symptoms onset.
The aim of this study is to describe the hospital-acquired influenza in a french university hospital of around 800 beds
Each patient or health-care worker who present ILI (influenza-like illness) at admission or during hospitalization. ILI is defined by fever > 37,8°C or/and cough or sore throat.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-Everyone who does not present the inclusion criteria.
Other: Questionnaire
An interview to collect some informations will be done: demographic informations, medical history, vaccination against influenza status, symptoms and virological informations. Then, a nasal swab was performed in order to identified the influenza virus.
Proportion of patients and health-care workers who present an influenza illness.
An interview to collect some informations will be done to evaluate if participants present symptoms of an inflenza illness (fever \> 37,8°C or/and cough or sore throat). Then, a nasal swab will be performed in order to identified the influenza virus.
Time frame: 5 days maximum
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Feb 2018; primary completion for Jun 2018, 4 months later.
Of 56 non-industry observational studies under Cross Infection, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 65. This study's planned 4 months is below that.
Counting every sponsor, half of 56 studies reached it within 28 months; a quarter within 17 and three quarters within 65.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.